Clinical Trial: Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study From Bangladesh

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06985134) titled 'Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study From Bangladesh' on May 13.

Brief Summary: the present study was conducted to determine the comparative efficacy and safety of thalidomide and SSZ in moderate to severe cases of ankylosing spondylitis in Bangladesh.

Study Start Date: Jan. 01, 2017

Study Type: INTERVENTIONAL

Condition: Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study From Bangladesh Condition ...Moderate to Severe Axial Spondyloarthopathy

Intervention: DR...